Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea
Seoul, 120-752, South Korea
NCT Number: NCT01857141
The use of epidural dexmedetomidine decreases the anaesthetic requirements and improved postoperative pain. Dexmedetomidine is a potent and highly selective a2-adrenoceptor agonist and has sympatholytic effect. Power spectral analysis of heart rate variability(HRV) is a useful tool to assess cardiac autonomic activity. We investigated whether preemptive epidural dexmedetomidine can develop hemodynamic change and it could be identify patients by HRV.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Seoul, 120-752, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in the pre-emptive groups recived a dose of 1.5㎍/kg dexmedetomidine dissolved into normal saline 10cc before the induction of
patients in the control groups received the equivalent volume of normal saline.
Time frame: 5min perioids after fluid resuscitation.
Heart rate variability analysis was performed according to the Task Force recommendations.
Frequency domain analysis was based on fast Fourier transformation. Power spectrum densities were calculated for low frequencies (LF: 0.04-0.15 Hz) and high frequencies (HF: 0.15-0.4 Hz) informalized units, defined as the LF or HF proportional part of the total power.
Baseline and 30min after the injection of the study drug.
Time frame: at 30 min after the epidural injection of the study drug
And secondary data collection was done at 30 min after the epidural injection of the study drug.
All of the HRV analysis was done before anaesthesia induction.
Looking for future studies?
Notify MeYonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00342654
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT07351474
Confusion, Delirium
Nanjing, Jiangsu, China
View Trial DetailsNCT04517708
Colon Cancer, Colonic Diseases
View Trial DetailsNCT05858736
Adenocarcinoma, Adnexal Diseases
Darlinghurst, New South Wales, Australia
View Trial Details